TBVI is continuously working on the development of new vaccine candidates.
The current TB vaccine pipeline (last update October 2018), is as follows:
TBVI provides technical support for product and clinical development to TB vaccine researchers and developers.
TB Vaccine development pathway
The TB vaccine pipeline requires a global and comprehensive coordination of efforts with defined stages of development and criteria for progression of individual vaccine candidates. To address this, the TB Vaccine Development Pathway is a newly established tool that provides a structured development path and gating criteria for TB vaccine candidates. It also describes the different functions and capabilities required to advance a candidate TB vaccine to its next stage of development. For more information about the Pathway, please visit www.TBVacPathway.org
For more information, please contact Daniëlle Roordink.